US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

670.73

+8.781.33%

Number of Gainers:93

Number of Losers:52

Number of Flat:8

PE:- -

High:672.66

Open:662.15

Low:661.43

Close:662.00

Volume:123.51M

Turnover:3.32B

Market Cap:463.86B

Float Cap:356.64B

Loading ...

Addex Therapeutics Brings Back Veteran Chemist to Lead Pharmaceutical Development as Pipeline Enters New Phase

Press Release: Addex Therapeutics Announces Executive Management Changes

Nexalis Therapeutics Appoints Non-Executive Chairman

MT Newswires Live

What Did The Market Misjudge About Alignment Healthcare?

Simply Wall St.

Major Investor Quietly Boosts Stake in Grace Therapeutics

Qyuns Therapeutics’ Oturkibart Shows Strong Phase III PN Data at EADV 2026

Zhihu-W (02390) Spends US$224,000 to Buy Back 184,600 Shares on September 30

Phillips Edison Reaffirms Fy2026 Nareit FFO Per Share Outlook at $2.67-$2.72

Phillips Edison & Company, - Increases Fy2026 Disposition Expectations to $200 Mln-$250 Mln

THOMSON REUTERS

Phillips Edison & Company Reaffirms Full Year 2026 Earnings Guidance; Increases Full Year 2026 Gross Acquisitions Guidance; Provides Investment Update

THOMSON REUTERS

Phillips Edison & Company, - Increases Fy2026 Gross Acquisitions Guidance to $600 Mln-$700 Mln

THOMSON REUTERS

Phillips Edison & Company, - Updates Fy2026 Core Ffo Per Share Diluted Guidance to $2.73-$2.79

THOMSON REUTERS

Pelthos Therapeutics Shareholders Back Directors and Equity Plan

Phillips Edison Expands Northwestern Mutual Joint Venture in $377.5 Million Shopping Center Deal

Phillips Edison & Company, - Joint Venture Term Extended by 10 Years to 2036

THOMSON REUTERS

Phillips Edison & Company, - Expansion to Occur in Stages, Additional Transfers Expected by Early 2027

THOMSON REUTERS

Phillips Edison & Company, - NorthWestern Mutual Retains 86% Interest, Peco Retains 14% Interest in Joint Venture

THOMSON REUTERS

Akari Therapeutics Enhances CEO Compensation, Equity Incentives

Traeger Appoints David R. Jolley to Board as Class III Director

Press Release: Ryan Specialty to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK4539/news?page=20"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":670.78046,"timestamp":1791563093272,"preClose":661.99634,"halted":0,"volume":123537935,"delay":0,"changeRate":0.013269,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":8.784119,"latestTime":"10-09 12:24:53 EDT","open":662.1523,"high":672.66296,"low":661.43115,"amount":3324579389.064406,"amplitude":0.016967,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.138586,"peRate":113.608055,"turnoverRate":0.009681,"increases":93,"decrements":52,"flats":5,"marketCap":463855664903.375,"floatMarketCap":356637984014.65625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":672.66296,"amplitude":0.016967,"preClose":661.99634,"low":661.43115,"pbRate":"5.138586","latestPrice":670.72833,"volume":123508877,"delay":0,"open":662.1523,"prevYearClose":881.5255,"prevWeekClose":665.7447,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":665.7447,"twentyDayClose":693.0266,"sixtyDayClose":732.057,"secType":"PLATE","market":"US","turnoverRate":0.009678,"peRate":113.608055,"marketCap":463814867871.375,"floatMarketCap":356605279706.65625,"timestamp":1791563088727,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":93,"down":52,"flat":8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:20,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672794954","title":"Addex Therapeutics Brings Back Veteran Chemist to Lead Pharmaceutical Development as Pipeline Enters New Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672794954","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672794954?lang=en_us&edition=fundamental","pubTime":"2026-10-02 13:32","pubTimestamp":1790919144,"startTime":"0","endTime":"0","summary":"Addex Therapeutics ( ($CH:ADXN) ) has shared an update. Addex Therapeutics has appointed veteran medicinal chemist Jean‑Philippe Rocher as Head of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/addex-therapeutics-brings-back-veteran-chemist-to-lead-pharmaceutical-development-as-pipeline-enters-new-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/addex-therapeutics-brings-back-veteran-chemist-to-lead-pharmaceutical-development-as-pipeline-enters-new-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","DBB","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672079179","title":"Press Release: Addex Therapeutics Announces Executive Management Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672079179","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672079179?lang=en_us&edition=fundamental","pubTime":"2026-10-02 13:00","pubTimestamp":1790917200,"startTime":"0","endTime":"0","summary":"-- Jean-Philippe Rocher Appointed Head of Pharmaceutical Development","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4539","BK4139","ADXN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672791441","title":"Nexalis Therapeutics Appoints Non-Executive Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2672791441","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672791441?lang=en_us&edition=fundamental","pubTime":"2026-10-02 12:55","pubTimestamp":1790916912,"startTime":"0","endTime":"0","summary":"Nexalis Therapeutics  appointed Niv Dagan to succeed Sean Williams as non-executive chairman, effective Friday, according to a same-day filing with the Australian bourse.Williams, who has served in the role since July 2021, is resigning to focus on other business commitments and family matters, per the filing.Dagan is the founder and executive director of boutique investment firm Peak Asset Management, the clinical-stage drug development company said. He is also currently the non-executive chairman of Spenda .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7043","SPX.AU","BK7096","BK4539","BK7007","NX1.AU","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672796012","title":"What Did The Market Misjudge About Alignment Healthcare?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672796012","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672796012?lang=en_us&edition=fundamental","pubTime":"2026-10-02 10:24","pubTimestamp":1790907870,"startTime":"0","endTime":"0","summary":"If you backed Alignment Healthcare for its rapid member growth, sub-10% SG&A, and bullish analyst narratives around digital care for seniors, the outcome was harsh. For Alignment Healthcare shareholders, the loss from the start of the year was 61.7%, including dividends. If you had bought on 1 January assuming 34.9% revenue growth, a 3.1% margin, and a 24.2x P/E by 2028, what did that thesis miss about regulatory risk, competition, and now, whistleblower accounting claims?\nNarratives are how...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice1-card/1789283981127","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice1-card/1789283981127"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/what-did-the-market-misjudge-about-alignment-healthcare","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/what-did-the-market-misjudge-about-alignment-healthcare","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XLV","XBI","BK4585","BK4581","BK4154","BK4588","LABU","BK4539","ALHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672796895","title":"Major Investor Quietly Boosts Stake in Grace Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2672796895","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672796895?lang=en_us&edition=fundamental","pubTime":"2026-10-02 10:03","pubTimestamp":1790906595,"startTime":"0","endTime":"0","summary":"New insider activity at Grace Therapeutics ( ($GRCE) ) has taken place on October 1, 2026. Significant shareholder Opaleye Management Inc. has incr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-grace-therapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-quietly-boosts-stake-in-grace-therapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672679805","title":"Qyuns Therapeutics’ Oturkibart Shows Strong Phase III PN Data at EADV 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672679805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672679805?lang=en_us&edition=fundamental","pubTime":"2026-10-02 08:07","pubTimestamp":1790899644,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. Class H ( ($HK:2509) ) has provided an update. Qyuns Therapeutics reported that results from its China Phase III trial...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-oturkibart-shows-strong-phase-iii-pn-data-at-eadv-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-oturkibart-shows-strong-phase-iii-pn-data-at-eadv-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164857276","title":"Zhihu-W (02390) Spends US$224,000 to Buy Back 184,600 Shares on September 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1164857276","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164857276?lang=en_us&edition=fundamental","pubTime":"2026-10-02 07:38","pubTimestamp":1790897891,"startTime":"0","endTime":"0","summary":"Zhihu-W (02390) announced that on September 30, 2026, it spent US$224,000 to repurchase 184,600 shares.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","BK4509","HK0000252152.HKD","BK4539","ZH","HK0000500386.USD","BK4077","02390","BK1095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672670697","title":"Phillips Edison Reaffirms Fy2026 Nareit FFO Per Share Outlook at $2.67-$2.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2672670697","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672670697?lang=en_us&edition=fundamental","pubTime":"2026-10-02 06:08","pubTimestamp":1790892524,"startTime":"0","endTime":"0","summary":"Phillips Edison reaffirms FY2026 Nareit FFO per share outlook at $2.67-$2.72Phillips Edison reaffirmed full-year 2026 guidance for net income per diluted share of $0.95-$0.97.Nareit FFO per diluted sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL5y110b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4112","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","BK4080","BK4231","SG9999014039.USD","PECO","SG9999014021.USD","LU2210150020.SGD","BCDF","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LU0314104364.USD","LU2210149790.SGD","BK4539","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BKPKM429.USD","NDAQ","IE00BQXX3F31.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672767066","title":"Phillips Edison & Company, - Increases Fy2026 Disposition Expectations to $200 Mln-$250 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2672767066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672767066?lang=en_us&edition=fundamental","pubTime":"2026-10-02 06:08","pubTimestamp":1790892506,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUAB2RS1W:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","BK4231","BK4539","PECO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672767065","title":"Phillips Edison & Company Reaffirms Full Year 2026 Earnings Guidance; Increases Full Year 2026 Gross Acquisitions Guidance; Provides Investment Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2672767065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672767065?lang=en_us&edition=fundamental","pubTime":"2026-10-02 06:08","pubTimestamp":1790892506,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUAB2RS1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4231","PECO","BK4080","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672068767","title":"Phillips Edison & Company, - Increases Fy2026 Gross Acquisitions Guidance to $600 Mln-$700 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2672068767","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672068767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 06:08","pubTimestamp":1790892506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUAB2RS1W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","PECO","BK4539","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672064767","title":"Phillips Edison & Company, - Updates Fy2026 Core Ffo Per Share Diluted Guidance to $2.73-$2.79","url":"https://stock-news.laohu8.com/highlight/detail?id=2672064767","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672064767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 06:08","pubTimestamp":1790892506,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUAB2RS1W:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4231","PECO","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672677617","title":"Pelthos Therapeutics Shareholders Back Directors and Equity Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672677617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672677617?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:52","pubTimestamp":1790891541,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics ( ($PTHS) ) just unveiled an announcement. On September 29, 2026, Pelthos Therapeutics held its 2026 Annual Meeting of Stockho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pelthos-therapeutics-shareholders-back-directors-and-equity-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pelthos-therapeutics-shareholders-back-directors-and-equity-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","REZ","LENZ","BK4215","BK4007","EQR","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672776729","title":"Phillips Edison Expands Northwestern Mutual Joint Venture in $377.5 Million Shopping Center Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2672776729","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672776729?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:49","pubTimestamp":1790891379,"startTime":"0","endTime":"0","summary":"Phillips Edison expands Northwestern Mutual joint venture in $377.5 million shopping center dealPhillips Edison expanded its joint venture with Northwestern Mutual, extending Grocery Retail Partners I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL6L401x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4080","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","BK4539","IE00BN0W2T93.GBP","NDAQ","BK4231","PECO","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BCDF","IE00BQXX3C00.GBP","LU2210150020.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672767298","title":"Phillips Edison & Company, - Joint Venture Term Extended by 10 Years to 2036","url":"https://stock-news.laohu8.com/highlight/detail?id=2672767298","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672767298?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:49","pubTimestamp":1790891360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA23DGCH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4231","BK4080","PECO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672376721","title":"Phillips Edison & Company, - Expansion to Occur in Stages, Additional Transfers Expected by Early 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2672376721","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672376721?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:49","pubTimestamp":1790891360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA23DGCH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4231","BK4080","BK4539","PECO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672293767","title":"Phillips Edison & Company, - NorthWestern Mutual Retains 86% Interest, Peco Retains 14% Interest in Joint Venture","url":"https://stock-news.laohu8.com/highlight/detail?id=2672293767","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672293767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:49","pubTimestamp":1790891360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA23DGCH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","BK4539","PECO","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672767433","title":"Akari Therapeutics Enhances CEO Compensation, Equity Incentives","url":"https://stock-news.laohu8.com/highlight/detail?id=2672767433","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672767433?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:20","pubTimestamp":1790889651,"startTime":"0","endTime":"0","summary":"An announcement from Akari Therapeutics ( ($AKTX) ) is now available. On September 29, 2026, Akari Therapeutics amended its chief executive officer...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akari-therapeutics-enhances-ceo-compensation-equity-incentives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akari-therapeutics-enhances-ceo-compensation-equity-incentives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","REZ","BK4539","BK4588","EQR","BK4215","BK4585","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672776200","title":"Traeger Appoints David R. Jolley to Board as Class III Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2672776200","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672776200?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:08","pubTimestamp":1790888938,"startTime":"0","endTime":"0","summary":"Traeger appoints David R. Jolley to board as Class III directorTraeger named David R. Jolley to its board, effective Oct. 1, 2026.Jolley will serve as a Class III director, with a term running to the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL8qKvfp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4191","BK4539","COOK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762444","title":"Press Release: Ryan Specialty to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762444?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:50","pubTimestamp":1790887800,"startTime":"0","endTime":"0","summary":"CHICAGO--(BUSINESS WIRE)--October 01, 2026--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (\"Ryan Specialty\"), a leading international specialty insurance firm, today announced it will release its Third Q","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RYAN","BK4539","BK4173"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":20,"totalSize":782,"code":"91000000","status":"200"}]}}